Human Anti-HIV-1 gp120 Monoclonal Antibodies with Neutralizing Activity Cloned from Humanized Mice Infected with HIV-1.
Document Type
Article
Publication Date
2-1-2019
Keywords
JMG
JAX Source
J Immunol 2019 Feb 1; 202(3):799-804
Volume
202
Issue
3
First Page
799
Last Page
804
ISSN
1550-6606
PMID
30593536
DOI
https://doi.org/10.4049/jimmunol.1801085
Grant
CA034196
Abstract
Broadly neutralizing, anti-HIV-1 gp120 mAbs have been isolated from infected individuals, and there is considerable interest in developing these reagents for Ab-based immunoprophylaxis and treatment. As a means to identify potentially new anti-HIV Abs, we exploited humanized NOD-scid IL2rγnull mice systemically infected with HIV-1 to generate a wide variety of Ag-specific human mAbs. The Abs were encoded by a diverse range of variable gene families and Ig classes, including IgA, and several showed significant levels of somatic mutation. Moreover, the isolated Abs not only bound target Ags with similar affinity as broadly neutralizing Abs, they also demonstrated neutralizing ability against multiple HIV-1 clades. The use of humanized mice will allow us to use our knowledge of HIV-1 gp120 structure and function, and the immune response targeting this protein, to generate native human prophylactic Abs to reduce the infection and spread of HIV-1.
Recommended Citation
Gawron M,
Duval M,
Carbone C,
Jaiswal S,
Wallace A,
Martin J,
Dauphin A,
Brehm M,
Greiner D,
Shultz LD,
Luban J,
Cavacini L.
Human Anti-HIV-1 gp120 Monoclonal Antibodies with Neutralizing Activity Cloned from Humanized Mice Infected with HIV-1. J Immunol 2019 Feb 1; 202(3):799-804